NICE has estimated that around 40% of people with COPD have elevated blood levels of eosinophils and, if half the eligible ...

Dupilumab, a simple pre-filled pen that people inject themselves with every two weeks, is the first biologic that targets both the symptoms of COPD and an underlying cause of the disease. It brings ...

A biologic injection that reduces chronic obstructive pulmonary disease (COPD) flare-ups by around a third has been approved for use on the NHS in England and Wales. The National Institute for Health ...

NICE has recommended dupilumab for adults with uncontrolled COPD and raised eosinophils, citing fewer exacerbations and ...

NICE has approved the first targeted treatment for chronic obstructive pulmonary disease (COPD), offering a new option to up ...

Sanofi and Regeneron’s Dupixent (dupilumab) has received positive final draft guidance from the National Institute for Health ...

Nearly 30,000 people in England living with chronic obstructive pulmonary disease could see their lives transformed after the ...

The National Institute for Health and Care Excellence (NICE), has published final draft guidance recommending dupilumab as a ...

In 1846, London surgeon John Hutchinson invented the spirometer — a thing a doctor normally asks asthma sufferers to blow hard into — to measure the volume of air inspired and expired by the lungs. It ...

UK ex-servicewomen are significantly more likely to experience health conditions such as COPD, osteoarthritis and obesity than civilian women, according to a comprehensive new research report ...

An AI-powered model that analyzes electrocardiograms was able to accurately detect COPD early in internal testing and ...